	US 11,938,106 B2
	Treatment of tinnitus using glutamate receptor agonists
Alexander V. Galazyuk, Kent, OH (US)
Assigned to NORTHEAST OHIO MEDICAL UNIVERSITY, Rootstown, OH (US)
Filed by Northeast Ohio Medical University, Rootstown, OH (US)
Filed on Apr. 18, 2022, as Appl. No. 17/723,313.
Application 17/723,313 is a continuation of application No. 15/999,753, granted, now 11,304,917, previously published as PCT/US2016/018572, filed on Feb. 19, 2016.
Prior Publication US 2023/0038631 A1, Feb. 9, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/196 (2006.01); A61P 27/16 (2006.01)

CPC A61K 31/196 (2013.01) [A61P 27/16 (2018.01)]

7 Claims

1. A method of treating tinnitus in a subject, comprising systemically administering a therapeutically effective amount of a group II metabotropic glutamate receptor (mGluR) agonist to the subject.